Electromagnetic Form Factors of Charged and Neutral Kaons

The charged and neutral kaon form factors are calculated as a phenomenological application of the QCD Dyson-Schwinger equations. The results are compared with the pion form factor calculated in the same framework and yield \mbox{$F_{K^\pm}(Q^2) > F_{\pi^\pm}(Q^2)$} on \mbox{$Q^2\in[0,3]$~GeV$^2$}; and a neutral kaon form factor that is similar in form and magnitude to the neutron charge form factor. These results are sensitive to the difference between the kaon and pion Bethe-Salpeter amplitude and the $u$- and $s$-quark propagation characteristics.Comment: 11 Pages, 2 figures, REVTEX, uses epsfig. No chang

Quark-Antiquark Bound States within a Dyson-Schwinger Bethe-Salpeter Formalism

Pion and kaon observables are calculated using a Dyson-Schwinger Bethe-Salpeter formalism. It is shown that an infrared finite gluon propagator can lead to quark confinement via generation of complex mass poles in quark propagators. Observables, including electromagnetic form factors, are calculated entirely in Euclidean metric for spacelike values of bound state momentum and final results are extrapolated to the physical region.Comment: Minor typographical corrections. Accepted for publication in Nucl. Phys.

Electromagnetic form factors of light vector mesons

The electromagnetic form factors G_E(q^2), G_M(q^2), and G_Q(q^2), charge radii, magnetic and quadrupole moments, and decay widths of the light vector mesons rho^+, K^{*+} and K^{*0} are calculated in a Lorentz-covariant, Dyson-Schwinger equation based model using algebraic quark propagators that incorporate confinement, asymptotic freedom, and dynamical chiral symmetry breaking, and vector meson Bethe-Salpeter amplitudes closely related to the pseudoscalar amplitudes obtained from phenomenological studies of pi and K mesons. Calculated static properties of vector mesons include the charge radii and magnetic moments: r_{rho+} = 0.61 fm, r_{K*+} = 0.54 fm, and r^2_{K*0} = -0.048 fm^2; mu_{rho+} = 2.69, mu_{K*+} = 2.37, and mu_{K*0} = -0.40. The calculated static limits of the rho-meson form factors are similar to those obtained from light-front quantum mechanical calculations, but begin to differ above q^2 = 1 GeV^2 due to the dynamical evolution of the quark propagators in our approach.Comment: 8 pages of RevTeX, 5 eps figure

The π\pi, K+K^+, and K0K^0 electromagnetic form factors

The rainbow truncation of the quark Dyson-Schwinger equation is combined with the ladder Bethe-Salpeter equation for the meson amplitudes and the dressed quark-photon vertex in a self-consistent Poincar\'e-invariant study of the pion and kaon electromagnetic form factors in impulse approximation. We demonstrate explicitly that the current is conserved in this approach and that the obtained results are independent of the momentum partitioning in the Bethe-Salpeter amplitudes. With model gluon parameters previously fixed by the condensate, the pion mass and decay constant, and the kaon mass, the charge radii and spacelike form factors are found to be in good agreement with the experimental data.Comment: 8 pages, 6 figures, Revte

Expressions 1983

The 1983 edition of Expressions magazine is the result of the efforts of students from several DMACC programs. Entrants in both the annual Creative Writing Contest and the Campus Chronicle Photography Contest as well as student in the commercial art program contributed material to the magazine. Layout, design and typesetting was done by the summer Publications Production class.https://openspace.dmacc.edu/expressions/1005/thumbnail.jp

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication